ClinicoEconomics and Outcomes Researchhttps://www.dovepress.com/feed/journal/29New articles released by Dove Press for ClinicoEconomics and Outcomes Researchen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press ClinicoEconomics and Outcomes ResearchClinicoEconomics and Outcomes Researchhttps://www.dovepress.com/feed/journal/29https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italyhttps://www.dovepress.com/cost-effectiveness-analysis-of-the-high-dose-trivalent-influenza-vacci-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchSat, 09 May 2026 04:15:00 +1200https://doi.org/10.2147/CEOR.S588333Research Gaps and Priorities for aHUS in the Gulf Cooperation Countries (GCC): Findings from a Payer-Focused Expert Meetinghttps://www.dovepress.com/research-gaps-and-priorities-for-ahus-in-the-gulf-cooperation-countrie-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 06 May 2026 00:55:00 +1200https://doi.org/10.2147/CEOR.S595064Cost-Effectiveness of Chondroitin Sulphate (with or without Glucosamine) Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBshttps://www.dovepress.com/cost-effectiveness-of-chondroitin-sulphate-with-or-without-glucosamine-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 06 May 2026 00:50:00 +1200https://doi.org/10.2147/CEOR.S577731Economic Burden of Overall and Advanced Light Chain Amyloidosis: Results from a Claims Linked Electronic Health Record Database Analysishttps://www.dovepress.com/economic-burden-of-overall-and-advanced-light-chain-amyloidosis-result-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchSat, 02 May 2026 00:40:00 +1200https://doi.org/10.2147/CEOR.S584774Semaglutide 2.4 mg for Obese Patients with MASH: A Cost-Effectiveness Analysis from the Italian NHS Perspectivehttps://www.dovepress.com/semaglutide-24-mg-for-obese-patients-with-mash-a-cost-effectiveness-an-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchFri, 01 May 2026 04:40:00 +1200https://doi.org/10.2147/CEOR.S585328Assessment of the Lifetime Costs of Severe Visual Impairment Due to Retinitis Pigmentosahttps://www.dovepress.com/assessment-of-the-lifetime-costs-of-severe-visual-impairment-due-to-re-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchFri, 24 Apr 2026 22:00:00 +1200https://doi.org/10.2147/CEOR.S571305Social Impact and Economic Burden of Uncoded Hyponatremia in Elderly – A Cost-of-Illness Studyhttps://www.dovepress.com/social-impact-and-economic-burden-of-uncoded-hyponatremia-in-elderly---peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchThu, 23 Apr 2026 15:20:00 +1200https://doi.org/10.2147/CEOR.S581335Discounting Practices in Cost-Effectiveness Analyses in Dentistry: A Systematic Review of Studies Published After 2020https://www.dovepress.com/discounting-practices-in-cost-effectiveness-analyses-in-dentistry-a-sy-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchSat, 18 Apr 2026 23:25:00 +1200https://doi.org/10.2147/CEOR.S600837Healthcare Resource Utilization and the Direct Medical Cost of Fibromyalgia Patients in a Tertiary Hospital in Saudi Arabiahttps://www.dovepress.com/healthcare-resource-utilization-and-the-direct-medical-cost-of-fibromy-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchThu, 16 Apr 2026 22:50:00 +1200https://doi.org/10.2147/CEOR.S578039Early Health Technology Assessment (HTA) of Olpasiran and Pelacarsen for Secondary Prevention of Coronary Heart Disease (CHD)https://www.dovepress.com/early-health-technology-assessment-hta-of-olpasiran-and-pelacarsen-for-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchThu, 16 Apr 2026 05:05:00 +1200https://doi.org/10.2147/CEOR.S583568Real-World Treatment Patterns in Patients with Atopic Dermatitis Initiating Ruxolitinib Cream: A 12-Month Follow-Up Analysis of a US Payer Claims Databasehttps://www.dovepress.com/real-world-treatment-patterns-in-patients-with-atopic-dermatitis-initi-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchSat, 11 Apr 2026 04:05:00 +1200https://doi.org/10.2147/CEOR.S569871Economic Burden of COVID-19 Hospitalization in Almaty, Kazakhstanhttps://www.dovepress.com/economic-burden-of-covid-19-hospitalization-in-almaty-kazakhstan-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchThu, 09 Apr 2026 03:20:00 +1200https://doi.org/10.2147/CEOR.S569792A Cost Analysis of Adverse Event Management of Systemic Therapies for Metastatic Colorectal Cancer on Patients with at Least Two Previous Lines of Treatment in Spainhttps://www.dovepress.com/a-cost-analysis-of-adverse-event-management-of-systemic-therapies-for--peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchTue, 07 Apr 2026 23:30:00 +1200https://doi.org/10.2147/CEOR.S586388Cost Minimization and Cost Comparison of the Use of Conventional Double Lumen Tube versus Single-Use VivaSight-Double Lumen Tube in Thoracic Surgery: The Pascale Institute Experiencehttps://www.dovepress.com/cost-minimization-and-cost-comparison-of-the-use-of-conventional-doubl-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchFri, 03 Apr 2026 03:25:00 +1300https://doi.org/10.2147/CEOR.S578308Real-World Progression-Free Survival and Healthcare Resource Utilization Associated with Daratumumab Use in Transplant-Ineligible Multiple Myeloma Patients in Italyhttps://www.dovepress.com/real-world-progression-free-survival-and-healthcare-resource-utilizati-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 01 Apr 2026 03:35:00 +1300https://doi.org/10.2147/CEOR.S585246Healthcare Utilization and Costs After Appropriate or Inappropriate Implantable Defibrillator Shocks: A Retrospective Real-World Data Study in Japanhttps://www.dovepress.com/healthcare-utilization-and-costs-after-appropriate-or-inappropriate-im-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchTue, 31 Mar 2026 19:15:00 +1300https://doi.org/10.2147/CEOR.S577970Effect of Drug Cost-Exemption Policy on Treatment Outcomes in Multidrug-Resistant Tuberculosis Patients in Guangxi Zhuang Autonomous Region, China: A Nested Case–Control Studyhttps://www.dovepress.com/effect-of-drug-cost-exemption-policy-on-treatment-outcomes-in-multidru-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchFri, 27 Mar 2026 22:00:00 +1300https://doi.org/10.2147/CEOR.S577874Activity-Based Costing of COVID-19 RT-PCR Testing in Public Laboratories in Indonesia: Evidence for Tariff Settinghttps://www.dovepress.com/activity-based-costing-of-covid-19-rt-pcr-testing-in-public-laboratori-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 18 Mar 2026 05:40:00 +1300https://doi.org/10.2147/CEOR.S596722Cost-Effectiveness and Clinical Utility of Pancreatic Cancer Non-Invasive Test in New-Onset Diabeteshttps://www.dovepress.com/cost-effectiveness-and-clinical-utility-of-pancreatic-cancer-non-invas-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchTue, 17 Mar 2026 18:45:00 +1300https://doi.org/10.2147/CEOR.S577796Association Between Willingness to Pay and Quality of Life in Acne Patients: A Cross-Sectional Study with a Nomogram for Individualized Predictionhttps://www.dovepress.com/association-between-willingness-to-pay-and-quality-of-life-in-acne-pat-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchFri, 13 Mar 2026 03:25:00 +1300https://doi.org/10.2147/CEOR.S579111Trends in Healthcare Costs in Heart Failure and Its Clinical Phenotypes During the Implementation of SGLT2 Inhibitors: A Finnish Registry Studyhttps://www.dovepress.com/trends-in-healthcare-costs-in-heart-failure-and-its-clinical-phenotype-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchThu, 12 Mar 2026 21:10:00 +1300https://doi.org/10.2147/CEOR.S576426Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST Studyhttps://www.dovepress.com/real-world-treatment-patterns-of-elranatamab-in-patients-with-multiple-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 11 Mar 2026 23:55:00 +1300https://doi.org/10.2147/CEOR.S581258The Early Cost-Effectiveness of a Novel Scalp Cooling Device to Alleviate Chemotherapy-Induced Alopecia in Patients with Early Breast Cancerhttps://www.dovepress.com/the-early-cost-effectiveness-of-a-novel-scalp-cooling-device-to-allevi-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchSun, 08 Mar 2026 03:40:00 +1300https://doi.org/10.2147/CEOR.S574046The Economic Impact of Loss to Follow-Up in Eosinophilic Esophagitis: A Model-Based Analysis from the Perspective of Italian National Health Servicehttps://www.dovepress.com/the-economic-impact-of-loss-to-follow-up-in-eosinophilic-esophagitis-a-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchMon, 02 Mar 2026 20:40:00 +1300https://doi.org/10.2147/CEOR.S551500Impact of Delaying Disease Recurrence on Economic Burden in Patients with HER2+ Early-Stage Breast Cancer (eBC)https://www.dovepress.com/impact-of-delaying-disease-recurrence-on-economic-burden-in-patients-w-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchFri, 20 Feb 2026 20:50:00 +1300https://doi.org/10.2147/CEOR.S560281Characteristics and Utilization Patterns of Medicare Beneficiaries Initiating Long-Acting Injectable Antipsychotic Medicationshttps://www.dovepress.com/characteristics-and-utilization-patterns-of-medicare-beneficiaries-ini-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchTue, 17 Feb 2026 21:10:00 +1300https://doi.org/10.2147/CEOR.S567370Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Testshttps://www.dovepress.com/economic-evaluation-of-combined-testing-strategies-using-erythrocyte-s-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 11 Feb 2026 06:00:00 +1300https://doi.org/10.2147/CEOR.S578961Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitorshttps://www.dovepress.com/budget-impact-of-secukinumab-in-psoriatic-arthritis-patients-with-cont-peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 11 Feb 2026 00:25:00 +1300https://doi.org/10.2147/CEOR.S570011Socio-Economic Impacts of Childhood Sickle Cell Disease on Households in Lubumbashi: An Exploratory Mixed-Methods Studyhttps://www.dovepress.com/socio-economic-impacts-of-childhood-sickle-cell-disease-on-households--peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchSat, 07 Feb 2026 00:00:00 +1300https://doi.org/10.2147/CEOR.S571343Economic Burden of Work-Related Low Back Pain in Indonesia Before and During the COVID-19 Era, 2019–2021: Analysis of Global Burden of Disease Estimateshttps://www.dovepress.com/economic-burden-of-work-related-low-back-pain-in-indonesia-before-and--peer-reviewed-fulltext-article-CEORClinicoEconomics and Outcomes ResearchWed, 04 Feb 2026 00:00:00 +1300https://doi.org/10.2147/CEOR.S575081